Kraematon Investment Advisors’s CRISPR Therapeutics CRSP Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-625
Closed -$25.4K 110
2022
Q4
$25.4K Buy
+625
New +$25.4K 0.03% 153